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Surgery for Congenital Heart Disease Hsu et alPerioperative B-type natriuretic peptide levels predict
outcome after bidirectional cavopulmonary
anastomosis and total cavopulmonary connection
Jong-Hau Hsu, MD,a,d Peter E. Oishi, MD,a Roberta L. Keller, MD,a Omar Chikovani, MD,a Tom R. Karl, MD,b
Anthony Azakie, MD,b Ian Adatia, MBChB,a and Jeffrey R. Fineman, MDa,cObjective: The objective of the study was to determine perioperative B-type natri-
uretic peptide levels in infants and children undergoing bidirectional cavopulmonary
anastomosis or total cavopulmonary connection, and the predictive value of B-type
natriuretic peptide levels for outcome.
Methods: Plasma B-type natriuretic peptide levels were measured before and 2, 12,
and 24 hours after surgery in 36 consecutive patients undergoing bidirectional cavo-
pulmonary anastomosis (n5 25) or total cavopulmonary connection (n5 11). B-type
natriuretic peptide levels were evaluated as predictors of outcome.
Results: B-type natriuretic peptide levels increased after surgery, peaking at 12
hours in most patients. In the bidirectional cavopulmonary anastomosis group, pa-
tients with 12-hour B-type natriuretic peptide $ 500 pg/mL had a longer duration of
mechanical ventilation (165 6 149 hours vs 20 6 9 hours, P 5 .004), longer in-
tensive care unit stay (11 6 7 days vs 4 6 2 days, P 5 .001), and longer hospital
stay (20 days 6 12 vs 9 days 6 5, P 5 .003). A 12-hour B-type natriuretic peptide
$ 500 pg/mL had a sensitivity of 80% and a specificity of 80% for predicting an
unplanned surgical or transcatheter cardiac intervention, including transplantation
(P 5 .03). In the total cavopulmonary connection group, preoperative B-type natri-
uretic peptide levels were highest in patients with total cavopulmonary connection
failure compared with patients with a good outcome (88 6 46 pg/mL vs 15 6 6 pg/
mL, P 5 .03).
Conclusion: Postoperative B-type natriuretic peptide levels predict outcome after
bidirectional cavopulmonary anastomosis, and preoperative levels are greater in
patients with both early and late total cavopulmonary connection failure compared
with patients with a good outcome.
S
urgical palliation of univentricular cardiac defects usually requires a series of
staged operations. Most often, the functionally single ventricle supplies blood
in parallel to the systemic and pulmonary circulations after first-stage pallia-
tion. A bidirectional cavopulmonary anastomosis (BCPA) followed by a total cavopul-
monary connection (TCPC) allows the transition of patients to a circulation in series,
wherein the functionally single ventricle ejects blood to the systemic vasculature while
passive venous return provides blood to the pulmonary vasculature. However, the ab-
sence of a dedicated subpulmonary ventricle requires the functionally single ventricle
to supply the total kinetic energy for blood flow through both circulations, which ren-
ders patients sensitive to elevations in pulmonary vascular resistance (PVR), valvular
dysfunction, or decreased ventricular performance.1-5 Although mortality after BCPA
and TCPC is low with careful patient selection, the ability to predict adverse postop-
erative outcomes is inadequate, and there remains an unpredictable risk of early and
late TCPC takedown because of poor adaptation to the Fontan circulation.
B-type natriuretic peptide (BNP) is a 32-amino acid polypeptide hormone secreted
by the myocardium in response to various stimuli that has natriuretic, diuretic, and
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DAbbreviations and Acronyms
BCPA 5 bidirectional cavopulmonary anastomosis
BNP 5 B-type natriuretic peptide
CPB 5 cardiopulmonary bypass
ICU 5 intensive care unit
LCOS 5 low cardiac output syndrome
mPAP 5 mean pulmonary artery pressure
PVR 5 pulmonary vascular resistance
Qp/Qs 5 ratio of pulmonary blood flow
over systemic blood flow
SVC 5 superior vena cava
SVEDP 5 systemic ventricular end-diastolic pressure
TCPC 5 total cavopulmonary connection
vasoactive properties.6,7 Recent studies found that BNP
levels predicted postoperative morbidity and mortality after
surgery for the repair or palliation of congenital cardiac de-
fects.8-11 However, these studies also demonstrated marked
variability in absolute BNP levels, perioperative changes in
BNP, and their specific predictive values, in part because of
differences between the specific age groups and cardiac de-
fects that were investigated.8-11 Thus, although the available
data demonstrate clinical utility for BNP as a biomarker in
subsets of patients after congenital cardiac surgery, they do
not directly establish a use in patients after BCPA or TCPC.
We hypothesized that perioperative BNP levelswould pre-
dict unexpected outcomes after BCPA and TCPC in patients
otherwise deemed to be suitable operative candidates on the
basis of standard preoperative hemodynamic assessments.
Therefore, the objectives of this study were (1) to determine
perioperative BNP levels in infants and children undergoing
BCPA or TCPC, and (2) to investigate the potential predictive
value of BNP levels for postoperative outcome.
Materials and Methods
We conducted a prospective cohort study in the pediatric cardiac in-
tensive care unit (ICU) at the University of California, San Francisco
Children’s Hospital between July of 2005 and July of 2006. Eligible
patients were children aged less than 17 years with congenital
cardiac defects who were undergoing BCPA or TCPC.
The preoperative anesthesia management, intraoperative surgi-
cal strategy, and subsequent pediatric cardiac ICU management fol-
lowed standard institutional practices. The surgical and medical
teams involved in the management of the patients were blinded to
the BNP values.
We obtained written informed consent from the patients’ parents
or guardians before enrollment in the study. The University of
California, San Francisco review board approved the study.
Data Collection
Blood samples were obtained from an arterial catheter just after in-
duction of anesthesia, and at 2, 12, and 24 hours after surgery. For
patients who could not be separated from cardiopulmonary bypass
(CPB), only the preoperative specimen was obtained. The samplesThe Journal of Thowere placed immediately on ice in chilled ethylenediamine tetraace-
tic acid-treated tubes and centrifuged at 3000 rpm for 15 minutes at
4C. Separated plasma was stored at 220C. Within 4 days, the
plasma was thawed to room temperature and BNP levels were mea-
sured using a commercially available fluorescence immunoassay
(Triage Meter Plus, Biosite Diagnostic, San Diego, Calif). The mea-
surable range of BNP on this device is between 5 and 5000 pg/mL.
The estimated coefficient of variation for the assay is 9.2% to 11.4%.
Perioperative clinical and biochemical data were collected
prospectively at each sampling point and daily thereafter by an ob-
server blinded to the BNP data. The clinical data collected included
the following: patient demographics; preoperative hemodynamic data
obtained at the time of cardiac catheterization, including the ratio of pul-
monary blood to systemic blood flow (Qp/Qs), PVR, mean pulmonary
artery pressure (mPAP), cardiac index, and systemic ventricular end-
diastolic pressure (SVEDP); CPB duration; and postoperative hemody-
namic and clinical outcomes, including inotrope dose, mean systemic
arterial pressure, common atrial pressure, heart rate, ICU and hospital
length of stay after operation, urine output, fluid balance 24 hours after
surgery, and duration ofmechanical ventilation. Perioperative biochem-
ical data collected included hematocrit, arterial and venous blood gases,
serum lactate, blood urea nitrogen, and creatinine.
Outcome Measures
The primary end point was the occurrence of an adverse outcome
within 1 year of surgery, defined as death or the need for an
unplanned surgical or transcatheter cardiac intervention, including
cardiac transplantation.
Secondary end points were the (1) duration of mechanical venti-
lation$ 48 hours postoperatively, (2) ICU length of stay, (3) hospital
length of stay, and (4) development of low cardiac output syndrome
(LCOS) within 48 hours after surgery. The definition of LCOS was
derived from criteria published by Hoffman and colleagues,12 which
included a combination of changes in clinical signs and biochemical
indicators. Criteria included tachycardia, oliguria, poor perfusion,
cardiac arrest, or metabolic acidosis, and the need for interventions
aimed at augmenting cardiac output, such as increased pharmaco-
logic support relative to the baseline and cardiac pacing.
Calculations
Inotrope use was quantified by a score adapted fromWernovsky and
colleagues.13 The score was calculated from the level of inotropic
support the patients were receiving (in micrograms/kilogram/
minute) at each sampling point according to the following equation:
dopamine 1 dobutamine 1 ½ðepinephrine 1 norepinephrineÞ 3
100 1 ðmilrinone 3 20Þ .
Data Analysis
Differences in the continuous variables between groups were tested
with the Student t test or Mann–Whitney U test. Differences in the
categoric variables between groups were tested with the Fisher exact
test. Correlations between variableswere performed by the Spearman
rank correlation method. The utility of BNP as a prognostic indicator
of postoperative outcome was evaluated using receiver operating
characteristic curves. Changes in BNP levels over time were com-
pared by repeated-measures analysis of variance. Statistical analyses
were performedwith Prism 4.0 (GraphPad Software, Inc, SanDiego,
Calif) and Stata 9.0 (Stata Corp, College Station, Tex).racic and Cardiovascular Surgery c Volume 135, Number 4 747




Thirty-six consecutive patients were enrolled in the study.
Twenty-five patients underwent BCPA, and 11 patients un-
derwent TCPC. Of the 25 patients in the BCPA group, 1 pa-
tient underwent a hemi-Fontan procedure, 2 patients had
bilateral superior venae cavae (SVC) with bilateral BCPA,
and the remainder underwent BCPA of a single SVC. All
11 patients in the TCPC group had an extracardiac conduit
placed between the inferior vena cava and the pulmonary
artery, 4 of which were fenestrated.
All patients had a cardiac catheterization performed
within 2 months before surgery. CPB was used in 32 patients
(89%). One patient could not be separated from CPB after
TCPC until the TCPCwas taken down. Only the preoperative
BNP value was included in the analysis for this patient.
The patients’ preoperative characteristics are shown in
Table 1. The younger patients undergoing BCPA had faster
heart rates, lower mean arterial pressure, higher mPAP, and
larger Qp/Qs ratios than those undergoing TCPC.
Outcomes
Primary end points. Seven patients (19%) had an adverse
outcome, 5 of 25 patients in the BCPA group and 2 of 11 pa-
tients in the TCPC group. The preoperative diagnoses and
specific postoperative events classifying the adverse out-
comes are shown in Table 2. No enrolled patient died during
the study period.
The demographic characteristics; degree of atrioventricu-
lar valve regurgitation; pre- and postoperative hemodynamic
indices; and postoperative creatinine, lactate, and inotrope
scores did not differ between patients undergoing BCPA
with and without an adverse outcome. Additional surgery
at the time of BCPA was required in 14 patients, including
pulmonary artery plasty, aortoplasty, atrial reduction, and
atrioventricular valve repair. The percentage of patients
requiring additional surgery did not differ between patients
with and without adverse postoperative outcome (55% vs
60%).
Preoperative hemodynamics fulfilled institutional criteria
for all patients undergoing a TCPC, including the 2 patients
with an adverse outcome. Of these 2 patients, 1 had Ebstein’s
anomaly with a hypoplastic right ventricle and total anoma-
lous pulmonary venous return that had been previously cor-
rected at the time of BCPA. This patient also underwent
atrial reduction at the time of TCPC. The second patient
had an unbalanced atrioventricular septal defect with right
atrial isomerism and anomalous right and middle hepatic
veins. This patient underwent unifocalization of the right
and middle hepatic veins at the time of TCPC. No patient
with a good outcome after TCPC required additional surgery.
Circulatory arrest was used during the operation for 2 pa-
tients undergoing BCPA, neither of whom had an adverse748 The Journal of Thoracic and Cardiovascular Surgery c Appostoperative outcome. No patient in the TCPC group under-
went circulatory arrest.
Secondary end points. Eight patients (22%) required
mechanical ventilation $ 48 hours postoperatively, 7 of
25 patients in the BCPA group and 1 of 11 patients in
TCPC group. The median duration of mechanical ventila-
tion was 22 hours (range: 8–373 hours) in patients who un-
derwent BCPA and 14 hours (range: 8–168 hours) in
patients who underwent TCPC. Seven patients (19%) de-
veloped LCOS within the first 48 hours after surgery, 4
of 25 patients in the BCPA group and 3 of 11 patients in
TCPC group. The ICU stay and hospital stay were 6 6 5
days and 13 6 9 days in the BCPA group, respectively,
and 6 6 2 days and 18 6 10 days in the TCPC group, re-
spectively.
TABLE 1. Preoperative characteristics
BCPA TCPC P
Patient No. 25 11
Age, mo 7.6 6 9.3 76.9 6 43.2
Weight, kg 6.4 6 2.3 20.3 6 11.4
Male, n (%) 17 (68%) 8 (73%) 1.0
Type of cardiac
lesion
8 HLHS 4 HLHS








1 TGA, VSD, HRV 1 Unbalanced
AVSD




Heart rate, min-1 129 6 18 92 6 11 ,.0001
Mean arterial
pressure, mm Hg
64 6 12 75 6 15 .04
Arterial oxygen
saturation,%
81 6 8 83 6 5 .36
Qp/Qs 1.6 6 0.7 0.8 6 0.3 .001
PVR (Wood's unit) 2.5 6 1.2 1.9 6 0.9 .12
Mean PA pressure,
mm Hg
16 6 4 11 6 4 .003
CI, L/min/m2 2.9 6 0.7 3.4 6 1.6 .20
SVEDP, mm Hg 9 6 3 9 6 4 .80
BCPA, Bidirectional cavopulmonary anastomosis; TCPC, total cavopulmo-
nary connection; Qp/Qs: ratio of pulmonary blood flow over systemic blood
flow; PVR, pulmonary vascular resistance; PA, pulmonary artery; CI, cardiac
index; SVEDP, systemic ventricular end-diastolic pressure; HLHS, hypoplas-
tic left heart syndrome;DORV, double outlet right ventricle;DILV, double inlet
left ventricle; PA-IVS, pulmonary atresia-intact ventricular septum; TGA,
transposition of great arteries; VSD, ventricular septal defect; HRV, hypo-
plastic right ventricle; PS, pulmonary stenosis; AVSD, atrioventricular septal
defect. Data are presented as mean 6 standard deviation.ril 2008
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DTABLE 2. Diagnoses and specific postoperative events of patients with an adverse outcome
Patient Surgery Diagnosis Outcome
1 BCPA d-TGA, VSD, HRV Reoperation for baffle leak and stenosis of the SVC-RPA junction at POD 3
2 BCPA DORV Transcatheter stent dilatation of residual LPA stenosis because of high SVC pressure at
POD 7
3 BCPA HLHS Transcatheter balloon dilatation for residual aortic arch stenosis at POD 7
4 BCPA DORV Transcatheter device closure of the pulmonary valve because of SVC and PA
hypertension secondary to pulsatile forward flow and device closure of a large
decompressing hemiazygous vein at POD 13
5 BCPA HLHS Transferred for cardiac transplant because of persistently poor RV function, decision
made at POD 12
6 TCPC Ebstein's anomaly, HRV Fontan circulation taken down in the OR because of failed Fontan circulation, unable to
separate from CPB; another MBTS was added in the same operation.
7 TCPC Unbalanced AVSD Fontan circulation taken down 11 mo after operation because of PLE; also had ECLS
because of profound LCOS at PODs 2–5
BCPA, Bidirectional cavopulmonary anastomosis; TCPC, total cavopulmonary connection; POD, postoperative day; d-TGA, dextraposed transposition of great
arteries; VSD, ventricular septal defect; HRV, hypoplastic right ventricle; DORV, double outlet right ventricle; HLHS, hypoplastic left heart syndrome; HRV,
hypoplastic right ventricle; AVSD, atrioventricular septal defect; SVC, superior vena cava; RPA, right pulmonary artery; LPA, left pulmonary artery; RV, right
ventricle; OR, operating room; CPB, cardiopulmonary bypass; PLE, protein-losing enteropathy; MBTS, modified Blalock-Taussig shunt; ECLS, extracorporeal
life support; LCOS, low cardiac output syndrome.Perioperative BNP Levels
Perioperative BNP levels are shown in Table 3. BNP levels
increased after surgery in all patients, with peak levels at
12 hours in 23 patients (66%) and at 24 hours in 8 patients
(23%). BNP levels were greater preoperatively and at 2 and
12 hours postoperatively in the BCPA group than in the
TCPC group (Table 3).
Preoperative BNP Levels and Outcome
BCPA group. Preoperative BNP levels were not different
between patients with or without an adverse outcome, mechan-
ical ventilation$ 48 hours, or LCOS, and there was no correla-
tion between preoperative BNP levels and ICU or hospital stay.
Preoperative BNP levels correlated with 2-hour BNP
levels (rho 5 0.84, P , .001), but not with 12- and 24-
hour BNP levels. There was no association between preoper-
ative BNP levels and sex, and preoperative BNP levels did
not correlate with preoperative weight, Qp/Qs, PVR,
mPAP, cardiac index, SVEDP, mean arterial pressure, heart
rate, arterial hemoglobin oxygen saturation, hematocrit,
serum lactate, blood urea nitrogen, or creatinine.
TCPC group. Preoperative BNP levels were greater in pa-
tients with an adverse outcome than in patients with a good
outcome (Figure 1). Preoperative BNP levels were not differ-
ent between patients with or without mechanical ventilationThe Journal of Thora$ 48 hours, or LCOS, and there was no correlation between
preoperative BNP levels and ICU or hospital stay.
Preoperative BNP levels correlated with 2-hour BNP
levels (rho 5 0.74, P 5 .03), but not with 12 and 24-hour
BNP levels. There was no association between preoperative
BNP levels and sex, and preoperative BNP levels did not cor-
relate with preoperative weight, Qp/Qs, PVR, mPAP, cardiac
index, SVEDP, mean arterial pressure, heart rate, arterial ox-
ygen saturation, hematocrit, serum lactate, urea, or creatinine.
Postoperative BNP Levels and Outcome
BCPA group. BNP levels at 12 and 24 hours were greater
in patients with an adverse outcome than in patients with
a good outcome (Figure 2). BNP levels at all postoperative
time points were greater in patients requiring mechanical
ventilation$ 48 hours (n5 7) than in patients requiring me-
chanical ventilation , 48 hours (n 5 18, P , .05). In addi-
tion, BNP levels at 2, 12, and 24 hours correlated with the
duration of mechanical ventilation (rho 5 0.44, P 5 .02;
rho 5 0.41, P 5 .04; rho 5 0.45, P 5 .02, respectively).
BNP levels at 12 hours were greater in patients who devel-
oped LCOS within 48 hours after surgery than in patients
who did not (913 6 693 pg/mL vs 308 6 299 pg/mL, P 5
.04). BNP levels at 2 hours correlated with ICU stay (rho
5 0.47, P 5 .01), and BNP levels at 2, 12, and 24 hoursTABLE 3. Perioperative B-type natriuretic peptide levels
Group Pre BNP (pg/mL) 2-h BNP (pg/mL) 12-h BNP (pg/mL) 24-h BNP (pg/mL) ANOVA P
BCPA (n 5 25) 105 6 119* (7–504) 118 6 137* (9–483) 405 6 431** (49–1860) 243 6 251 (37–1140) ,.0001
TCPCy (n 5 11) 28 6 33 (5–121) 26 6 21 (8–79) 117 6 89 (38–334) 121 6 113 (22–403) .001
BNP, B-type natriuretic peptide; ANOVA, analysis of variance; BCPA, bidirectional cavopulmonary anastomosis; TCPC, total cavopulmonary connection. Data
are presented as mean 6 standard deviation (range). *P , .05. **P , .01 vs TCPC group. yn 5 10 at 2, 12, and 24 hours.cic and Cardiovascular Surgery c Volume 135, Number 4 749
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Dcorrelated with hospital stay (rho 5 0.56, P 5 .003; rho 5
0.40, P 5 .04; rho 5 0.39, P 5 .04, respectively).
There were no correlations between postoperative BNP
levels and mean arterial pressure, common atrial pressure,
arterial oxygen saturation, hematocrit, urea, creatinine, or
duration of CPB.
Receiver operating characteristic curves were used to
evaluate various cutoff values of 12-hour BNP to predict
an adverse outcome and mechanical ventilation $ 48 hours.
A 12-hour BNP cutoff value of$ 500 pg/mL had a sensitivity
of 80% and a specificity of 80% for predicting an adverse out-
come (area under the curve: 0.81, P 5 .03). A 12-hour BNP
cutoff value of $ 500 pg/mL had a sensitivity of 86% and
a specificity of 89% for predicting mechanical ventilation
$ 48 hours (area under the curve: 0.82, P 5 .01).
Because a 12-hour BNP level $ 500 pg/mL predicted
both an adverse outcome and mechanical ventilation $ 48
hours, we dichotomized patients by BNP levels of , 500
pg/mL or $ 500 pg/mL. The characteristics of patients
with a 12-hour BNP level , 500 pg/mL and $ 500 pg/mL
are shown in Table 4. Patients with a 12-hour BNP level $
500 pg/mL had a greater incidence of LCOS and a longer
ICU and hospital stay than patients with a 12-hour BNP level
, 500 pg/mL (Table 4).
TCPC group. Postoperative BNP levels were not differ-
ent between patients with or without an adverse outcome,
mechanical ventilation $ 48 hours, or LCOS, and there
was no correlation between postoperative BNP levels and
length of ICU or hospital stay.
Other Variables and Outcome
Age and preoperative hemodynamic data obtained from car-
diac catheterizations were not associated with any primary or
Figure 1. Comparisons of preoperative BNP levels between
patients with (n 5 2) and without (n 5 9) adverse outcome after
TCPC. Horizontal lines 5 mean values. BNP, B-type natriuretic
peptide; TCPC, total cavopulmonary connection.750 The Journal of Thoracic and Cardiovascular Surgery c Apsecondary outcomes. We examined further the relationship
between serum lactate and outcome. We found that 24-hour
lactate levels were correlated with the duration of mechanical
ventilation (rho5 0.52, P5 .01). In addition, 24-hour lactate
levels were greater in patients who required mechanical ven-
tilation $ 48 hours than in patients who did not (1.3 6 0.4
mmol/L vs 0.8 6 0.2 mmol/L; P 5 .01). However, the
mean lactate values in both groups were within the normal
range for our laboratory.
Discussion
These data indicate that BNP levels predict outcome after
BCPA and suggest a potential prognostic role for BNP before
TCPC. Although lactate levels at 24 hours were correlated
with the duration of mechanical ventilation, no other hemo-
dynamic or biochemical data were associated with postoper-
ative outcome. Previously identified risk factors for patients
undergoing BCPA include atrioventricular valve regurgita-
tion, elevated pulmonary artery pressure, a systemic right
ventricle, anomalous pulmonary venous drainage, tricuspid
valvuloplasty, elevated SVEDP, bilateral SVC, unbalanced
atrioventricular septal defect, and heterotaxy syndrome.1,3,14
Although the present study was not designed primarily to
evaluate individual risk factors for outcome after BCPA,
we did not find an association between these factors and out-
come, making BNP levels uniquely predictive of outcome
after BCPA in this study.
Of the 11 patients undergoing TCPC in our study, 2 pa-
tients required takedown to a BCPA. Preoperative BNP
levels were greatest in these patients. General criteria of
Figure 2. Comparison of perioperative BNP levels between
patients with adverse or good outcome after BCPA. BNP levels
at 12 and 24 hours are greater in patients with adverse outcome
(n 5 5) than in patients with good outcome (n 5 20). There was
a significant interaction between outcome and sample time
(P < .01). Data are presented as mean 6 standard error. (*P < .05
and **P < .01 vs good outcome.) BNP, B-type natriuretic peptide;
BCPA, bidirectional cavopulmonary anastomosis.ril 2008
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DTABLE 4. Characteristics of patients undergoing bidirectional cavopulmonary anastomosis with a 12-hour B-type
natriuretic peptide level < or $ 500 pg/mL
12-h BNP level <500 pg/mL 12-h BNP level $500 pg/mL P
Patient No. (%) 17 (68%) 8 (32%)
Age, mo 7.8 6 10.6 7.2 6 6.1 .97
Weight, kg 5.9 6 1.7 6.4 6 2.5 .60
Male, n (%) 12 (71%) 5 (62%) 1.0
Preoperative hemodynamic data
Qp/Qs 1.7 6 0.8 1.3 6 0.5 .22
PVR, Wood's unit 2.5 6 1.4 2.7 6 1.1 .74
Mean PA pressure, mm Hg 15 6 3 17 6 5 .23
CI, L/min/m2 2.7 6 0.7 3.4 6 0.8 .08
SVEDP, mm Hg 10 6 3 8 6 2 .17
Postoperative data at 12 h
Heart rate, min-1 120 6 14 127 6 16 .31
Mean arterial pressure, mm Hg 71 6 10 70 6 10 .82
Common atrial pressure, mm Hg 7 6 3 8 6 2 .91
Serum creatinine, mg/dL 0.4 6 0.1 0.5 6 0.1 .11
Serum lactate, mmol/L 1.1 6 0.6 1.2 6 0.5 .83
Inotrope score 9 6 4.5 12 6 6.5 .23
Outcomes
LCOS, n (%) 1 (6%) 3 (38%) .08
ICU length of stay, d 4 6 2 11 6 7 .001
Hospital length of stay, d 9 6 5 20 6 12 .003
Duration of mechanical ventilation, h 20 6 9 165 6 149 .004
Adverse outcome, n (%) 1 (6%) 4 (50%) .02
BNP, B-type natriuretic peptide; Qp/Qs: ratio of pulmonary blood flow over systemic blood flow; PVR, pulmonary vascular resistance; PA, pulmonary artery; CI,
cardiac index;SVEDP, systemic ventricular end-diastolic pressure; LCOS, low cardiac output syndrome; ICU, intensive care unit. Data are presented asmean6
standard deviation.suitability for TCPC have been described and include normal
systemic venous return, mPAP less than 15 mm Hg, low
PVR, good ventricular function, a competent atrioventricular
valve, and the absence of pulmonary artery distortion.5 With
the exception of 1 patient with a good outcomewho had a pre-
operative mPAP greater than 15 mmHg (but also an elevated
left atrial pressure and a normal calculated PVR), all of the
patients met these criteria. These findings suggest that preop-
erative BNP levels may provide valuable supplemental data
to aid in decisions regarding the timing or advisability of
a TCPC.
We found that BNP levels increased after BCPA and
TCPC. This finding is in contrast with a study by Sun and
colleagues15 that found no change in BNP levels after
BCPA or Fontan. Because preoperative, but not postopera-
tive, BNP levels were greater in their cohort than ours, the in-
consistency between groups may be explained by differences
in preoperative hemodynamics. In a study of 9 patients that
included 4 patients after TCPC, Ationu and colleagues16 re-
ported decreases in BNP after surgery. However, in a larger
study of 30 patients after TCPC, Yoshimura and colleagues17
found that BNP levels increased postoperatively in a manner
similar to patients in our study. Furthermore, in a study of 25
patients that included 5 patients with BCPA and 5 patientsThe Journal of Thorwith TCPC, Costello and colleagues18 found that BNP levels
increased after surgery in both groups and correlated with
CPB time. A relationship between perioperative BNP levels
and outcome was not found in any of these prior studies, and
thus the present study is the first to suggest a prognostic role
for BNP in this patient population.
The regulation of BNP production and release in health
and disease remains incompletely understood. However, in
vivo and in vitro investigations demonstrate that ventricular
volume and pressure loading increase BNP expression.19-21
In addition, several stimuli relevant to patients undergoing
cardiac surgery, including catecholamines, endothelin-1,
and cytokines, have been demonstrated to increase BNP ex-
pression.21,22 Last, several additional factors with particular
importance for patients with single ventricle physiology
have been correlated with BNP levels, including hypoxia
and the Qp/Qs ratio.23,24 In the present study, preoperative
BNP levels were greater in patients before BCPA than
TCPC. This result is consistent with several previous stud-
ies, but not all.18,25-28 However, our findings are in keeping
with increased volume and pressure loading after stage 1
palliation, reflected by higher mPAP and larger Qp/Qs ra-
tios in patients before BCPA compared with patients before
TCPC.acic and Cardiovascular Surgery c Volume 135, Number 4 751
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DThe mechanisms underlying the greater increase in BNP
in patients with an adverse outcome are likely variable, but
speculative. Three patients with an adverse outcome had re-
sidual defects that resulted in increased SVC pressure and de-
creased pulmonary blood flow. A recent study by Law and
colleagues25 of patients with cavopulmonary connections
found that BNP levels increased with ventricular failure but
not with isolated cavopulmonary failure, defined as systemic
venous congestion without evidence of ventricular dysfunc-
tion. The study of Law and colleagues included mostly an
outpatient population, whereas the present study focused on
the immediate perioperative period. In addition, because pa-
tients with an adverse outcome in our study also had an in-
creased incidence of LCOS, it is possible that the patients
with residual anatomic defects of the cavopulmonary circuit
also had ventricular dysfunction or an elevated afterload. One
patient with an adverse outcome in the BCPA group required
transcatheter aortic dilation for residual aortic arch obstruction.
The elevation in BNP in this patient is consistent with previous
reports after relief of left ventricular outflow tract obstruction.29
Finally, the mechanisms responsible for an elevation in preop-
erative BNP in patients with an adverse outcome after TCPC
are unclear, particularly given that the preoperative hemody-
namics were not different from patients with good outcome.
We speculate that because BNP is a cardiac hormone, it may
reflect myocardial dynamics in a unique manner that is more
sensitive than current diagnostic methods.
We chose the duration of mechanical ventilation as a sec-
ondary end point because it is a common surrogate marker of
disease severity that has been correlated to BNP levels in pre-
vious studies of patients after congenital cardiac surgery.8-10
Given the potential deleterious effects of positive pressure
ventilation and salutary effects of spontaneous respiration
for patients with superior or complete cavopulmonary con-
nections, our institutional practice is to separate patients
from mechanical ventilation as early in their postoperative
course as possible. Indeed, mechanical ventilation beyond
48 hours, the specific end point used in our study, is unusual,
and thus represents an unexpected clinical outcome. It must
be noted that there are no validated criteria for the discontin-
uation of mechanical ventilation for patients after BCPA or
TCPC, and thus the decision to separate a patient from the
ventilator was made on an individual basis by the attending
physicians, who were blinded to the BNP values.
In addition, we used the development of LCOS as a sec-
ondary outcome, because it has been used as an end point
in therapeutic trials in pediatric patients after cardiac sur-
gery.12 However, the majority of patients with LCOS devel-
oped it early in the postoperative course, before the 12-hour
time point. Thus, postoperative BNP levels did not predict
LCOS, but rather were associated with it. Whether therapies
initiated in response to elevated BNP levels in the postoper-
ative period could decrease the incidence of LCOS was not
evaluated, but this warrants further study.752 The Journal of Thoracic and Cardiovascular Surgery c AprA limitation of this study is the sample size. Only 2 pa-
tients had a poor outcome after TCPC. However, because
BNP was the only predictor of outcome, we suggest that it
was an important finding and at least warrants a larger
prospective study that would permit multivariate analysis.
Conclusions
We found that postoperative BNP levels predict important
outcomes after BCPA and that a cutoff of 500 pg/mL 12
hours after surgery was a sensitive and specific predictor of
an unplanned cardiac intervention andmechanical ventilation
beyond 48 hours. In addition, we found that preoperative
BNP levels were greater in patients with early or late take-
down of the TCPC than in those with a successful operation.
Additional studies are warranted to define further the role of
BNP in the management of these patients, but our study sug-
gests that elevated BNP levels after BCPA should prompt
a careful evaluation of hemodynamics and ventricular func-
tion, an investigation of the surgical accuracy of the anasto-
mosis, and a search for additional anatomic defects. We
suggest that BNP levels may be useful in the preoperative
evaluation of patients considered for a TCPC.
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